Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Comment by Sandblaster1980on Aug 22, 2020 4:41pm

317 Views

Post# 31442213

RE:In Vitro

Let's say the estimate of 563 billion is off by half that would be 281 billion dollars in the in vitro market and Sona can only get a measly 5% of the market. 5% of 281 billion =14,050,000,000 billion over the next 5 years and per year could be 2,810,000,000 billion. Wow. Just need those field studies and FDA stamp to start up this $$ machine. GLTA.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec